2021
DOI: 10.1007/s00253-021-11356-1
|View full text |Cite
|
Sign up to set email alerts
|

Marine microbial L-glutaminase: from pharmaceutical to food industry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 73 publications
0
12
0
Order By: Relevance
“…Even though these enzymes have been characterized from a wide range of different sources, microbial fibrinolytic enzymes are considered attractive tools due to their features, such as enhanced specificity [8], low production cost [8], comparatively high yield [28] and the possibility to be genetically modified by recombinant DNA technology and protein engineering approaches [29]. Marine ecosystems serve as a reservoir of microorganisms producing important therapeutic metabolites, especially enzymes [30][31][32][33][34][35][36][37][38][39], but they remain largely unexplored to date. Due to the wide biodiversity of the marine environment, marine microorganisms can provide a diverse array of enzymes for biotechnological development, with possible improved pharmacological properties and lesser side effects [40].…”
Section: Introductionmentioning
confidence: 99%
“…Even though these enzymes have been characterized from a wide range of different sources, microbial fibrinolytic enzymes are considered attractive tools due to their features, such as enhanced specificity [8], low production cost [8], comparatively high yield [28] and the possibility to be genetically modified by recombinant DNA technology and protein engineering approaches [29]. Marine ecosystems serve as a reservoir of microorganisms producing important therapeutic metabolites, especially enzymes [30][31][32][33][34][35][36][37][38][39], but they remain largely unexplored to date. Due to the wide biodiversity of the marine environment, marine microorganisms can provide a diverse array of enzymes for biotechnological development, with possible improved pharmacological properties and lesser side effects [40].…”
Section: Introductionmentioning
confidence: 99%
“…Fungal aspartic proteases from A. niger are used for the preparation of digestive powders [22]. L-glutaminase from Aspergillus fumigatus and Penicillium allii is used for the treatment of leukaemia by inhibiting the growth of cancerous cells [214]. Alkaline protease is also used as a digestible in the pharmaceutical industry to treat cystic fibrosis [215,216].…”
Section: Medical and Pharmaceutical Industrymentioning
confidence: 99%
“…Likewise, marine species of Aureobasidium pullulans, black yeast, has also been reported for EG and exoglucanase production [80]. Despite the biotechnological importance of marine-derived enzymes [81][82][83], the biotechnological application of marine-derived cellulolytic yeast has yet to be established.…”
Section: Cellulolytic Yeastsmentioning
confidence: 99%